Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Body Composition × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 1 Oligomenorrhea 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Insulin Resistance 1 Hyperandrogenism 1 Hodgkin Disease 1 Hirsutism 1 Fatigue 1 Diabetes Mellitus, Type 1 1 Depression 1 Congenital Abnormalities 1 Breast Neoplasms 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05188755 2022-12-23

CUPCAKE

University Hospital, Clermont-Ferrand

Phase NA Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡